scientific design, conduct, analysis & reporting of clinical trials

Lagakos' Symposium

"Impact of Biostatistical Science - Advances in Research:

AIDS, Cancer, Environment"

Richard Gelber

Richard D. Gelber, PhD is Professor of Biostatistics and Computational Biology at Dana-Farber Cancer Institute, Professor of Pediatrics at Harvard Medical School, and Professor of Biostatistics at the Harvard School of Public Health, Boston, Massachusetts, USA.  

He pioneered the Q-TWiST (Quality-adjusted Time Without Symptoms of disease and Toxicity of treatment) method, which provides a framework to examine the benefits of disease control against the burdens of treatment side effects.  He recently developed a new statistical method called STEPP (Subpopulation Treatment Effect Pattern Plot), which illustrates how beneficial a particular treatment might be for groups of patients who share a characteristic such as age or a continuous biomarker value. Dr. Gelber has directed the Statistical Center for the International Breast Cancer Study Group since 1978. This consortium of institutions conducts Phase III clinical trials for adjuvant therapy for breast cancer. He is currently the senior biostatistician for two major studies of adjuvant treatment for HER2-positive breast cancer conducted by the Breast International Group (the HERA and ALTTO trials). He is an elected fellow of the American Statistical Association and has received several awards in recognition of his work, including the 2008 Brinker Award for Scientific Distinction in Clinical Research granted by Susan G. Komen for the Cure.

Personal webpage

Frontier Science Foundation-Hellas 2007-2011